FDA NDC Directory · JSON-LD · Markdown

Tyvaso DPI

NDC 66302-764 · HUMAN PRESCRIPTION DRUG · INHALANT

Generic nametreprostinil
Labeler / ManufacturerUnited Therapeutics Corporation
Marketing categoryNew Drug Application (innovator) · App NDA214324
Dosage form / routeINHALANT · ORAL
Active ingredientsTREPROSTINIL (64 ug/1)
Marketing started20220523
Package count1

External sources

Source: openFDA. Public-domain (CC0).